OTCMKTS:MMNFF

MedMen Enterprises Stock Forecast, Price & News

$0.19

+0.01 (+4.32 %)

(As of 01/15/2021 08:27 PM ET)

Add

Compare

Today's Range

$0.18

Now: $0.19▼

$0.20

50-Day Range

$0.12

MA: $0.15▼

$0.20

52-Week Range

$0.09

Now: $0.19▼

$0.65

Volume8.05 million shs

Average Volume6.82 million shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

MedMen Enterprises Inc., through its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, distributes, and retails recreational and medicinal cannabis under the [statemade], LuxLyte, and MedMen Red brand names. It operates 25 retail stores in 6 states. MedMen Enterprises Inc. was founded in 2010 and is headquartered in Culver City, California.

Overall MarketRank^™

0.76 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for MedMen Enterprises.

3.8 Community Rank

Outperform Votes
MedMen Enterprises has received 134 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
MedMen Enterprises has received 41 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
MedMen Enterprises has received 76.57% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about MedMen Enterprises and other stocks. Vote “Outperform” if you believe MMNFF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MMNFF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
MedMen Enterprises does not currently pay a dividend.
Dividend Growth
MedMen Enterprises does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, MedMen Enterprises insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,404,696.00 in company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Drug Manufacturers - Specialty & Generic

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:MMNFF

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.medmen.com

Phone855-292-8399

Employees1,000

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

$0.19

+0.01 (+4.32 %)

(As of 01/15/2021 08:27 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive MMNFF News and Ratings via Email

Sign-up to receive the latest news and ratings for MMNFF and its competitors with MarketBeat's FREE daily newsletter.

MedMen Enterprises (OTCMKTS:MMNFF) Frequently Asked Questions

How has MedMen Enterprises' stock been impacted by COVID-19?

MedMen Enterprises' stock was trading at $0.1539 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MMNFF shares have increased by 25.4% and is now trading at $0.1930.
View which stocks have been most impacted by COVID-19.

Is MedMen Enterprises a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MedMen Enterprises in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" MedMen Enterprises stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MMNFF, but not buy additional shares or sell existing shares.
View analyst ratings for MedMen Enterprises or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than MedMen Enterprises?

Wall Street analysts have given MedMen Enterprises a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but MedMen Enterprises wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting MedMen Enterprises?

MedMen Enterprises saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 3,814,200 shares, an increase of 28.3% from the December 15th total of 2,973,400 shares. Based on an average daily trading volume, of 12,632,600 shares, the short-interest ratio is currently 0.3 days.
View MedMen Enterprises' Short Interest.

Who are some of MedMen Enterprises' key competitors?

Some companies that are related to MedMen Enterprises include (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Abacus Health Products (ABAHF), Acreage (ACRGF), Althea Group Holdings Limited (AGH.AX) (AGH), Applied Biosciences (APPB), AusCann Group Holdings Ltd (AC8.AX) (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE) and CannPal Animal Therapeutics Limited (CP1.AX) (CP1).
View all of MMNFF's competitors.

Who are MedMen Enterprises' key executives?

MedMen Enterprises' management team includes the following people:

Mr. Adam Nathaniel Bierman, Co-Founder (Age 39, Pay $1.15M)
Mr. Michael Jay Lane, Chief Information Officer (Age 49, Pay $253.72k)
Mr. Zeeshan Hyder, Exec. Officer (Age 33, Pay $541.56k)
Mr. Thomas Jerome Lynch, Interim CEO & Chairman and Chief Restructuring Officer (Age 52)
Mr. Reece Fulgham, Interim Chief Financial Officer (Age 59)
Mr. Timothy Bossidy, Interim Chief Operating Officer (Age 32)
Mr. Dan Edwards, Sr. VP of Legal Affairs
Christian Langbein, VP of Communications
Mr. Felix Popescu, Sr. VP of Strategic Planning

What is MedMen Enterprises' stock symbol?

MedMen Enterprises trades on the OTCMKTS under the ticker symbol "MMNFF."

How do I buy shares of MedMen Enterprises?

Shares of MMNFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MedMen Enterprises' stock price today?

One share of MMNFF stock can currently be purchased for approximately $0.19.

What is MedMen Enterprises' official website?

The official website for MedMen Enterprises is www.medmen.com.

How can I contact MedMen Enterprises?

The company can be reached via phone at 855-292-8399.

This page was last updated on 1/18/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here